We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at where Acadia Healthcare Company Inc (NASDAQ:ACHC) stands against other top falling stocks with unusual volume.
Uncertainty around tariffs and macroeconomic conditions has dented investor confidence, resulting in stock prices falling. While some stocks have come under pressure due to the above two reasons, others have simply followed the market direction or have dipped for company-specific reasons.
Regardless of the reasons for stocks going down, falling stocks provide an opportunity for fresh investors to get in at good prices. Once the risks subside, these stocks usually recover quickly as well. We decided to uncover these stocks and see if it makes sense to put money in them to take advantage of the ongoing market turmoil.
To come up with our list of top 20 stocks falling with unusual volume, we looked at stocks over $300 million in market cap, their one-week performance, and used relative volume to detect the unusual volume activity.
Relative volume compares the daily volume to the three-month average trading volume of the stock, making it easy to detect spikes in volume. These spikes usually signal something important is happening, which, when combined with falling prices, becomes a red flag that investors can’t ignore.
A healthcare professional discussing a treatment plan with a patient in an outpatient clinic.
Acadia Healthcare Company Inc (NASDAQ:ACHC)
Acadia Healthcare Company Inc (NASDAQ:ACHC) is a behavioral healthcare services provider. It operates and develops comprehensive treatment centers, acute inpatient psychiatric facilities, residential treatment centers, and specialty treatment facilities comprising residential recovery facilities and eating disorder facilities. The firm’s stock is down 11.71% in a week on a relative volume of 3.17.
The company earned an upgrade at the start of this year. KeyBanc Capital Markets analyst Matthew Gillmor upgraded the firm from Sector Weight to Overweight on the back of an expected potential momentum of its EBITDA in 2026. He assigned a price target of $70 to Acadia Healthcare Company Inc (NASDAQ:ACHC).
Analyst Matthew Gillmor stated:
“We think valuation can begin to normalize during 2025 (to >9x), as negative press headlines from 2024 fade and 2026 EBITDA comes into focus.”
A similar sentiment was shown by another analyst only a few days ago. Guggenheim analyst Jason Cassorla upgraded the stock to Buy with a price target of $36. He was optimistic about the long-term outlook of the industry.
The company’s valuation seems attractive regardless of the current market conditions. However, there is no meaningful short-term catalyst for the business itself, so the direction of the broader market may well determine investor returns in this case.
Overall, ACHC ranks 8th on our list of top falling stocks with unusual volume. While we acknowledge the potential of ACHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ACHC but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.